Literature DB >> 23312288

Adaptive downregulation of mitochondrial function in down syndrome.

Pablo Helguera1, Jaqueline Seiglie, Jose Rodriguez, Michael Hanna, Gustavo Helguera, Jorge Busciglio.   

Abstract

Mitochondrial dysfunction and oxidative stress are common features of Down syndrome (DS). However, the underlying mechanisms are not known. We investigated the relationship between abnormal energy metabolism and oxidative stress with transcriptional and functional changes in DS cells. Impaired mitochondrial activity correlated with altered mitochondrial morphology. Increasing fusion capacity prevented morphological but not functional alterations in DS mitochondria. Sustained stimulation restored mitochondrial functional parameters but increased reactive oxygen species production and cell damage, suggesting that reduced DS mitochondrial activity is an adaptive response for avoiding injury and preserving basic cellular functions. Network analysis of genes overexpressed in DS cells demonstrated functional integration in pathways involved in energy metabolism and oxidative stress. Thus, although preventing extensive oxidative damage, mitochondrial downregulation may contribute to increased susceptibility of individuals with DS to clinical conditions in which altered energy metabolism may play a role, such as Alzheimer's disease, diabetes, and some types of autistic spectrum disorders.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312288      PMCID: PMC3580189          DOI: 10.1016/j.cmet.2012.12.005

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  24 in total

Review 1.  Molecular motors in the nervous system.

Authors:  S T Brady
Journal:  Neuron       Date:  1991-10       Impact factor: 17.173

2.  Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue.

Authors:  R H Andres; A D Ducray; A W Huber; A Pérez-Bouza; S H Krebs; U Schlattner; R W Seiler; T Wallimann; H R Widmer
Journal:  J Neurochem       Date:  2005-07-25       Impact factor: 5.372

3.  Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.

Authors:  Jorge Busciglio; Alejandra Pelsman; Caine Wong; Gustavo Pigino; Menglan Yuan; Hiroshi Mori; Bruce A Yankner
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

4.  ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.

Authors:  Pablo Helguera; Alejandra Pelsman; Gustavo Pigino; Ernst Wolvetang; Elizabeth Head; Jorge Busciglio
Journal:  J Neurosci       Date:  2005-03-02       Impact factor: 6.167

5.  Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury.

Authors:  Giuseppe Esposito; Jaime Imitola; Jie Lu; Daniele De Filippis; Caterina Scuderi; Vijay S Ganesh; Rebecca Folkerth; Jonathan Hecht; Soojung Shin; Teresa Iuvone; Jonathan Chesnut; Luca Steardo; Volney Sheen
Journal:  Hum Mol Genet       Date:  2007-11-05       Impact factor: 6.150

6.  Down syndrome and comorbid autism-spectrum disorder: characterization using the aberrant behavior checklist.

Authors:  George T Capone; Marco A Grados; Walter E Kaufmann; Susana Bernad-Ripoll; Amy Jewell
Journal:  Am J Med Genet A       Date:  2005-05-01       Impact factor: 2.802

7.  Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology.

Authors:  Tianzheng Yu; James L Robotham; Yisang Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

8.  Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway.

Authors:  Daniela Valenti; Gabriella Arcangela Manente; Laura Moro; Ersilia Marra; Rosa Anna Vacca
Journal:  Biochem J       Date:  2011-05-01       Impact factor: 3.857

9.  Oxidative Stress and Mitochondrial Dysfunction in Down's Syndrome: Relevance to Aging and Dementia.

Authors:  Pinar E Coskun; Jorge Busciglio
Journal:  Curr Gerontol Geriatr Res       Date:  2012-04-29

10.  Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.

Authors:  Rakez Kayed; Elizabeth Head; Floyd Sarsoza; Tommy Saing; Carl W Cotman; Mihaela Necula; Lawrence Margol; Jessica Wu; Leonid Breydo; Jennifer L Thompson; Suhail Rasool; Tatyana Gurlo; Peter Butler; Charles G Glabe
Journal:  Mol Neurodegener       Date:  2007-09-26       Impact factor: 14.195

View more
  53 in total

1.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

2.  Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Antonella Tramutola; Alessandra Giorgi; Maria Eugenia Schininà; Raffaella Coccia; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2014-03-25       Impact factor: 7.376

3.  Down Syndrome Critical Region 1 Gene, Rcan1, Helps Maintain a More Fused Mitochondrial Network.

Authors:  Valentina Parra; Francisco Altamirano; Carolina P Hernández-Fuentes; Dan Tong; Victoriia Kyrychenko; David Rotter; Zully Pedrozo; Joseph A Hill; Verónica Eisner; Sergio Lavandero; Jay W Schneider; Beverly A Rothermel
Journal:  Circ Res       Date:  2018-01-23       Impact factor: 17.367

4.  Mitochondrial mRNA expression in fibroblasts of Down syndrome subjects.

Authors:  Michele Salemi; Mariaconcetta Giambirtone; Concetta Barone; Maria Grazia Salluzzo; Roberto Russo; Mariangela Lo Giudice; Salvatore Cutuli; Federico Ridolfo; Corrado Romano
Journal:  Hum Cell       Date:  2018-03-03       Impact factor: 4.174

5.  Analysis of Heteroplasmic Variants in the Cardiac Mitochondrial Genome of Individuals with Down Syndrome.

Authors:  Erik Hefti; Jonathan Bard; Javier G Blanco
Journal:  Hum Mutat       Date:  2016-09-26       Impact factor: 4.878

Review 6.  Stem and progenitor cell dysfunction in human trisomies.

Authors:  Binbin Liu; Sarah Filippi; Anindita Roy; Irene Roberts
Journal:  EMBO Rep       Date:  2014-12-17       Impact factor: 8.807

Review 7.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

8.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

9.  Nerve growth factor metabolic dysfunction in Down's syndrome brains.

Authors:  M Florencia Iulita; Sonia Do Carmo; Alison K Ower; Ashley M Fortress; Lisi Flores Aguilar; Michael Hanna; Thomas Wisniewski; Ann-Charlotte Granholm; Mona Buhusi; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2014-02-11       Impact factor: 13.501

10.  High throughput gene complementation screening permits identification of a mammalian mitochondrial protein synthesis (ρ(-)) mutant.

Authors:  Prasanth Potluri; Vincent Procaccio; Immo E Scheffler; Douglas C Wallace
Journal:  Biochim Biophys Acta       Date:  2016-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.